Evidence map›Paper›PMID 32500040›Full record

ArticleFrontiers in cellular and infection microbiology2020

Epidemiology of

Albert Dunbar, Alexander Schauwvlieghe, Sheruna Algoe, Jaap J van Hellemond, Marijke Reynders, Stefaan Vandecasteele, Jerina Boelens, Pieter Depuydt, Bart Rijnders

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 43 citations in OpenAlex.

  1. Challenges and opportunities in the management of severe pneumonia. Key concepts from the Seventh Annual Meeting of Spanish Experts 2025.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2026
    Review
  2. Article
  3. Article
  4. Radiation Recall Pneumonitis withDiseases (Basel, Switzerland) · 2025
    Article
  5. The 2025 EQUALJAC-antimicrobial resistance · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Study on the Prevalence ofBiomedicines · 2023
    Article
  15. Article
  16. Lung microbiome and origins of the respiratory diseases.Current research in immunology · 2023
    Review
  17. Article
  18. Molecular and microscopy detection ofFrontiers in medicine · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Albert DunbarDepartment of Internal Medicine, Infectious Diseases, Erasmus University Medical Center, Rotterdam, Netherlands.
Alexander SchauwvliegheDepartment of Internal Medicine, Infectious Diseases, Erasmus University Medical Center, Rotterdam, Netherlands.
Sheruna AlgoeDepartment of Internal Medicine, Infectious Diseases, Erasmus University Medical Center, Rotterdam, Netherlands.
Jaap J van HellemondDepartment of Medical Microbiology & Infectious Diseases, Erasmus University Medical Center, Rotterdam, Netherlands.
Marijke ReyndersDepartment of Laboratory Medicine, Medical Microbiology, AZ St-Jan Brugge-Oostende Hospital, Bruges, Belgium.
Stefaan VandecasteeleDepartments of Nephrology and Infectious Diseases, AZ St-Jan Brugge-Oostende Hospital, Bruges, Belgium.
Jerina BoelensDepartment of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.
Pieter DepuydtDepartment of Intensive Care Medicine, Ghent University Hospital, Ghent, Belgium.
Bart RijndersDepartment of Internal Medicine, Infectious Diseases, Erasmus University Medical Center, Rotterdam, Netherlands.
Erasmus MC · NLAZ Sint-Jan · BEGhent University Hospital · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pneumocystis cariniiPneumonia, PneumocystisHumansImmunocompromised HostReal-Time Polymerase Chain ReactionRetrospective Studiesimmunocompromidsed patientsPneumocystic jirovecii pneumoniaPneumocystis jiroveci (carinii) pneumoniaprophylaxisTrimetoprim- sulfamethoxazole

Identifiers

PMID32500040
PMCPMC7243458
OpenAlexW3025386656

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.